Eveline Barbieri
- Baylor College of Medicine · Pediatrics (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #12,391
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14884289Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-4368-1451Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pediatrics
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#12,391
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Eveline Barbieri as a PI. Multi-PI records show the full award amount for context.
- 4R01CA283369-03R01Contact PIRewired Metabolism and Immunosuppression in MYCN-driven NeuroblastomaBaylor College of Medicine · Pediatrics (NIH department code)$1.3Maward amount
- 5R21CA300631-02R21Contact PIMYCN drives a suppressive tumor immune microenvironment in neuroblastoma.Baylor College of Medicine · Pediatrics (NIH department code)$187.6Kaward amount
- 1R03NS140939-01A1R03Contact PIA NOVEL GEMM TO ELUCIDATE THE ROLE OF CHAF1A IN NEUROBLASTOMA DEVELOPMENTBaylor College of Medicine · Pediatrics (NIH department code)$160.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing Eveline Barbieri as a PI.
FY2026 award administered by Baylor College of Medicine (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBaylor College of Medicine
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding